Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on June 2, 2025
Why More Doctors Should Speak Spanish: NHMA 2025 Conference Tackles Language Gaps in Health Care
EIN Presswire
·
June 2, 2025
NHMA’s 2025 Conference (June 5–7) spotlights the need for more Spanish-speaking doctors to improve care, trust, and outcomes for Latino patients. ANAHEIM, CA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- With over 1.9 million Californians …
PayToMe.co Joins NVIDIA Inception to Tackle $46B SMB Finance Problem With AI
EIN Presswire
·
June 2, 2025
NVIDIA Inception supports PayToMe.co’s mission to empower 400M SMBs with real-time payments, compliance automation, and global AI infrastructure. SAN FRANCISCO, CA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- 🚀 PayToMe.co, an award-winning AI- …
Clarifying ABOG's Mission and the Certification Process
GlobeNewswire
·
June 2, 2025
Dallas, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- The American Board of Obstetrics and Gynecology (ABOG) acknowledges the perspectives and concerns raised by attorneys general regarding the safety and accessibility of in-person certification exams, …
Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors
GlobeNewswire
·
June 2, 2025
ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest clinical …
Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report
GlobeNewswire
·
June 2, 2025
ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from …
Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568
GlobeNewswire
·
June 2, 2025
Tokyo, Japan and Cambridge, UK, 3 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that its partner, Neurocrine Biosciences (“Neurocrine”) has dosed the first patient in its Phase 3 registrational program of NBI- …
Saus Trades’ Latest eBook Helps Traders Tackle the Psychological Barriers to Consistent Profitability
GlobeNewswire
·
June 2, 2025
The Trader’s Mind bridges the gap between strategy and success, offering tools like trading journals, breathing techniques, and mindset frameworks. Designed for daily use, it’s been embraced by over 20,000 traders, earning a 4.5-star rating. Photo Courtesy …
Canadian Health Tech Cuts Hospital Emergency Department Triage Time by up to 60%
GlobeNewswire
·
June 2, 2025
Photo Courtesy of EmergConnect TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- EmergConnect’s digital platform helps hospitals cut ER triage time by up to 60%. The system gives patients real-time wait estimates, supports nursing staff, and is gaining traction …
Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders
GlobeNewswire
·
June 2, 2025
VICTORIA, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to …
Kura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
– CR/CRh rate of 23% in pivotal Ph 2 cohort of R/R NPM1-m AML patients – – Consistent efficacy with comparable CR/CRh rates and clinically meaningful MRD-negative responses across pre-specified subgroups, regardless of prior HSCT, prior venetoclax, or FLT3 …
Evils of Sham Peer Review Exposed in the Journal of American Physicians and Surgeons
GlobeNewswire
·
June 2, 2025
TUSCON, Ariz., June 02, 2025 (GLOBE NEWSWIRE) -- Unlike good-faith peer review intended to ensure good patient care, the intent of sham peer review is to inflict maximum harm on the physician victim, in pursuit of power, control, or money, writes Lawrence …
West Edmonton Primary Care Network clinic opening at Kickstand Edmonton youth hub
GlobeNewswire
·
June 2, 2025
EDMONTON, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- Kickstand Edmonton, operated by YMCA of Northern Alberta is a free youth services site in West Edmonton Mall, offering mental health counselling, Indigenous wellness, life skills training and more to …
Quest PharmaTech Provides Corporate Update
GlobeNewswire
·
June 2, 2025
EDMONTON, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary …
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Harvard Bioscience Appoints John Duke to Board of Directors
GlobeNewswire
·
June 2, 2025
HOLLISTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and nominating …
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 23,820 restricted stock units (“RSUs”) to six newly-hired non-executive employees under the Company’s 2025 …
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes
GlobeNewswire
·
June 2, 2025
MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …
Vaxart Announces Adjournment of Annual Meeting of Stockholders
GlobeNewswire
·
June 2, 2025
Meeting adjourned to June 13, 2025 at 8:30 a.m. Pacific Time Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 12, 2025 Leading Independent Proxy Advisory Firms, ISS and Glass …
Sernova Appoints Jonathan Rigby as Interim Chair
GlobeNewswire
·
June 2, 2025
LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 …
Kickstand youth hub now includes the West Edmonton Primary Care Network on site
GlobeNewswire
·
June 2, 2025
EDMONTON, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- Starting June 4, Kickstand Edmonton operated by YMCA of Northern Alberta will now offer primary healthcare services for youth at its free youth wellness services hub located in West Edmonton Mall. Young …